Table 2.

Changes over time in the U.S population, incident cases and proportion of cases who received an autologous HCT

Calendar Year		1994–1995	1996–1997	1998–1999	2000–2001	2002–2003	2004–2005
Total U.S population aged 0–74 years, in millions		249.9	255.5	261.2	266.8	271.6	276.5
Acute Myeloid Leukemia (AML)	Incidence rate per 100,000 persons	5.2	5.0	5.2	5.5	5.0	4.7
	Number of new incident cases aged 0–74 years	12,879	12,683	13,682	14,608	13,532	13,131
	Rate of AutoHCTs aged 0–74 years per New Incident cases	6.6%	5.3%	5.5%	3.9%	4.8%	5.0%
Acute Lymphoblastic Leukemia (ALL)	Incidence rate per 100,000 persons	2.9	3.0	3.0	3.0	3.1	3.3
	Number of new incident cases aged 0–74 years	7,706	7,592	7,926	8,055	8,404	9,067
	Rate of AutoHCTs aged 0–74 years per New Incident cases	2.6%	1.5%	1.3%	0.7%	0.4%	0.6%
Myelodysplastic syndrome/ Myeloproliferative disorder (MDS/MPS)	Incidence rate per 100,000 persons	*	*	*	*	3.8	3.9
	Number of new incident cases aged 0–74 years	*	*	*	*	10,226	10,764
	Rate of AutoHCTs aged 0–74 years per New Incident cases	*	*	*	*	0.2%	0.2%
Non-Hodgkin lymphoma (NHL)	Incidence rate per 100,000 persons	29.5	28.4	27.9	28.0	28.7	29.4
	Number of new incident cases aged 0–74 years	73,658	72,650	72,925	74,614	77,973	81,272
	Rate of AutoHCTs aged 0–74 years per New Incident cases	4.9%	5.9%	5.6%	5.3%	4.6%	4.5%
Hodgkin Lymphoma (HL)	Incidence rate per 100,000 persons	5.1	5.2	5.3	5.1	5.2	5.3
	Number of new incident cases aged 0–74 years	12,787	13,330	13,856	13,707	14,212	14,706
	Rate of AutoHCTs aged 0–74 years per New Incident cases	9.4%	10.0%	10.8%	10.1%	10.0%	10.3%
Multiple Myeloma (MM)	Incidence rate per 100,000 persons	7.4	7.4	7.5	7.7	7.7	8.0
	Number of new incident cases aged 0–74 years	18,422	19,006	19,498	20,468	20,863	22,123
	Rate of AutoHCTs aged 0–74 years per New Incident cases	5.1%	9.8%	15.6%	18.3%	22.6%	25.1%

^*SEER did not initiate data collection for MDS/MPD until 2001.